×
Home Current Archive Editorial Team
Contact
Issue image

Vol 23, No 1, (2026)

All issues

[ Forthcoming Issue ]: This issue is in progress but contains articles that are fully citable.

Contents

27.02.2026. Original article New and Emerging Medical Entities In the next Issue
Risk factors for red blood cell alloimmunization in polytransfused patients

ABSTRACT Aim Alloimmunization depends on the type of the erythrocyte antigen, as well as the number of transfused doses of blood and recipient factors reflected in genetic and immunological status, comorbidities and therapy. The aim was to determine the frequency and type of antierythrocyte antibodies, to examine the correlation between the number...

By SVETLANA JOVIĆ LACKOVIĆ, ALMIRA ĆOSIĆKIĆ

27.02.2026. Meta-analysis New and Emerging Medical Entities In the next Issue
Prophylactic use of rectal diclofenac in mitigating post endoscopic retrograde cholangiopancreatography pancreatitis risk and severity: low- vs high-dose efficacy and timing strategies— a meta-analysis

Aim Post endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is the most prevalent adverse event with significant morbidity following ERCP. Several guidelines have suggested the use of rectal diclofenac as a promising option to prevent PEP. Nonetheless, the recommended optimal dose and timing of administration remain unclear. T...

By MAGGIE LIBERTY, TAUFIK SUNGKAR, PEGGY LIBERTY

Recent issues

View Archive